.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
West Coast Cure is stocked at 342 licensed dispensaries across California, Maine, and Washington, 340 of them in California, with the deepest coverage in Los Angeles, Santa Ana, Long Beach, Costa Mesa, and Fresno. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, West Coast Cure concentrated nearly half of sales in Vapor Pens at 48.45% share, where category sales rose 8.96% month over month despite a 1.14% year-over-year dip, while the brand’s overall sales were down 14.63% year over year and 38.86% vs. 24 months. Flower lifted 18.48% month over month but remained 42.90% down year over year, and Pre-Roll inched up 1.44% month over month while falling 16.21% year over year; Concentrates were almost flat year over year at -0.13% with a 6.57% month-over-month gain, and Edible declined both month over month (-16.47%) and year over year (-32.59%). With Vapor Pens ranked 12 in California and the average price down 6.70% year over year to $19.14, the pattern implies the brand is leaning on price-adjusted recovery in inhalables to offset structural contraction in Flower and persistent weakness in low-share Edibles.
The mix shift—+8.96% month-over-month growth in Vapor Pens paired with a 48.45% share and a 6.57% month-over-month lift in Concentrates—suggests West Coast Cure is consolidating around core inhalable formats where velocity can be regained through pricing, while a -42.90% year-over-year decline in Flower and a -32.59% year-over-year decline in Edible point to selective de-emphasis of underperforming SKUs. Holding 12th rank in California Vapor Pens alongside a 18.48% month-over-month rebound in Flower indicates a tactical push to stabilize rankings via depth in high-penetration categories, implying the brand’s near-term positioning hinges on defending share in Vapor Pens and Concentrates while using targeted, price-led experiments to test whether Flower’s month-over-month uptick can translate into sustained rank and share gains.
Competitive Landscape
West Coast Cure sits at rank #12 in California Vapor Pens in September 2026, a 2-position improvement from #14 year over year and a 1-position lift from #13 three months ago; however, its peak of #11 in October 2024 indicates a ceiling the brand has not surpassed. Competitively, STIIIZY held at #1 year over year while posting a -16.7% sales change, and Jetty Extracts climbed from #4 to #3 with a 45.2% sales increase, suggesting that West Coast Cure’s modest rank gains are occurring amid divergent leader trajectories. The pattern implies West Coast Cure is edging up the mid-tier but needs a sharper share-accretive move to break past the #11–#12 band as competitors either consolidate at the top or accelerate upward.
Notable Products
CUREpen - Skywalker OG Distillate Cartridge (1g) led September 2026 with a 50.3% MoM jump and a move to rank 1, outpacing Curepen - Granddaddy Purple Distillate Cartridge (1g) at rank 3 with a 33.8% MoM increase and CUREpen - Northern Lights Distillate Cartridge (1g) at rank 5 with a 14.8% lift. Eight of the top ten SKUs are Vapor Pens, concentrated from ranks 1 through 10 with only one Pre-Roll breaking into rank 2 at a -2.0% MoM dip, implying the portfolio’s sell-through is tilting decisively toward inhalables that scale on flavor variants rather than format diversification. The top Vapor Pens cohort also includes new or N/A-MoM entries like CUREpen - Watermelon Mojito Distillate Cartridge (1g) at rank 4 and CUREbar 2.0 - Juicy Blueberries Live Resin Disposable (1g) at rank 9, while the CUREbar 2.0 - Gelato Z Live Resin Disposable (1g) holds rank 10 without a reported MoM read, indicating expansion across both 510 and disposable formats within the same month. The mix implies West Coast Cure is prioritizing cartridge and disposable breadth over Pre-Roll depth to defend rank positions 1 through 10 and compound gains above +30% on multiple leaders.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
